Cancer Cell Biology

You have full text access to this OnlineOpen article

Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention

  1. Alfonso Catalano1,†,*,
  2. Laura Graciotti1,
  3. Luciana Rinaldi1,2,
  4. Giorgia Raffaelli1,
  5. Sabrina Rodilossi1,
  6. Piergiacomo Betta3,
  7. Walter Gianni4,
  8. Salvatore Amoroso5,‡,
  9. Antonio Procopio1,‡

Article first published online: 9 JAN 2004

DOI: 10.1002/ijc.11710

Issue

International Journal of Cancer

International Journal of Cancer

Volume 109, Issue 3, pages 322–328, 10 April 2004

Additional Information

How to Cite

Catalano, A., Graciotti, L., Rinaldi, L., Raffaelli, G., Rodilossi, S., Betta, P., Gianni, W., Amoroso, S. and Procopio, A. (2004), Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention. Int. J. Cancer, 109: 322–328. doi: 10.1002/ijc.11710

Author Information

  1. 1

    Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Ancona, Italy

  2. 2

    Institute of Urology, Polytechnic University of Marche, Ancona, Italy

  3. 3

    Pathology Unit, Department of Oncology, Azienda Ospedaliera Nazionale SS, Antonio e Biagio e C. Arrigo, Alessandria, Italy

  4. 4

    U.O. Oncologia, Istituto Nazionale di Riposo e Cura per Anziani (INRCA), Rome, Italy

  5. 5

    Department of Pharmacology, Polytechnic University of Marche, Ancona, Italy

  1. †

    Fax: +39-071-2204618

  2. ‡

    Dr. Amoroso and Dr. Procopio share the senior authorship of this work.

*Dipartimento di Patologia Molecolare e Terapie Innovative, Università Politecnica delle Marche, Via Ranieri 31, 60131, Ancona, Italy

Publication History

  1. Issue published online: 6 FEB 2004
  2. Article first published online: 9 JAN 2004
  3. Manuscript Accepted: 15 OCT 2003
  4. Manuscript Revised: 12 SEP 2003
  5. Manuscript Received: 11 JUN 2003

Funded by

  • Associazione Italiana per la Ricerca sul Cancro (AIRC)
  • Italian Ministero dell'Università e della Ricerca Scientifica

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (350K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vijay Agarwal, Michael J. Lind, Lynn Cawkwell, Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: Where do we stand?, Cancer Treatment Reviews, 2011, 37, 7, 533

    CrossRef

  2. 2
    Sara L. O’Kane, Gina L. Eagle, John Greenman, Michael J. Lind, Lynn Cawkwell, COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines, Lung Cancer, 2010, 67, 2, 160

    CrossRef

  3. 3
    Xin-Jiang Wu, Ying Hu, Evelyn Lamy, Volker Mersch-Sundermann, Apoptosis induction in human lung adenocarcinoma cells by oil-soluble allyl sulfides: Triggers, pathways, and modulators, Environmental and Molecular Mutagenesis, 2009, 50, 3
    Direct Link:
  4. You have free access to this content4
    Yuhua Li, Yinbo Niu, Huanjie Wu, Bangle Zhang, Yang Sun, Haitao Huang, Qian Li, Lei Fan, Li Liu, Qibing Mei, PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo, Cancer Science, 2009, 100, 12
    Direct Link:
  5. 5
    B.-J. Zheng, K.-W. Chan, Y.-P. Lin, G.-Y. Zhao, C. Chan, H.-J. Zhang, H.-L. Chen, S. S. Y. Wong, S. K. P. Lau, P. C. Y. Woo, K.-H. Chan, D.-Y. Jin, K.-Y. Yuen, Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus, Proceedings of the National Academy of Sciences, 2008, 105, 23, 8091

    CrossRef

  6. 6
    Axel H. Schönthal, Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy, Neurosurgical FOCUS, 2006, 20, 4, E21

    CrossRef

  7. 7
    S. Grosch, T. J. Maier, S. Schiffmann, G. Geisslinger, Cyclooxygenase-2 (COX-2)-Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors, JNCI Journal of the National Cancer Institute, 2006, 98, 11, 736

    CrossRef

  8. 8
    Jonathan E. Dowell, Hedy Lee Kindler, Antiangiogenic Therapies for Mesothelioma, Hematology/Oncology Clinics of North America, 2005, 19, 6, 1137

    CrossRef

  9. 9
    Uwe Zangemeister-Wittke, Sally Hopkins-Donaldson, Apoptosis regulation and drug resistance in malignant pleural mesothelioma, Lung Cancer, 2005, 49, S105

    CrossRef

  10. 10
    S.L. O’Kane, L. Cawkwell, A. Campbell, M.J. Lind, Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma, European Journal of Cancer, 2005, 41, 11, 1645

    CrossRef

  11. 11
    Priya Kumar, Robert A. Kratzke, Molecular prognostic markers in malignant mesothelioma, Lung Cancer, 2005, 49, S53

    CrossRef

View Full Article (HTML) Get PDF (350K)